AI-based pathomics model predicts regulatory T cell infiltration and radiotherapy response in IDH-wild-type glioblastoma
Frontiers in Immunology · 21.05.2026 · 17
DOI: 10.3389/fimmu.2026.1817892 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Immunology, online erschienen am 21.05.2026. Verfasst von Shaoli Peng und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, Cancer Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China. Hauptthemen laut MEDLINE: Glioblastoma, T-Lymphocytes, Regulatory, Brain Neoplasms, Artificial Intelligence. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Regulatory T cells (Tregs) contribute significantly to immune suppression and therapy resistance in isocitrate dehydrogenase (IDH)-wild-type glioblastoma (GBM), a highly aggressive brain tumor with poor prognosis.
Methods
In this study, we developed an artificial intelligence (AI)-powered pathomics model to predict Treg infiltration and stratify prognosis in GBM patients undergoing radiotherapy. Using high-dimensional features extracted from hematoxylin and eosin-stained biopsies, we constructed a pathomics score (PS) via gradient boosting after feature selection with Minimum Redundancy Maximum Relevance (mRMR) and Relief algorithms.
Results
The model demonstrated strong predictive performance across multi-center cohorts (n > 300), where high PS was significantly associated with elevated Treg levels and reduced overall survival (TCGA: HR = 2.16; validation cohort: HR = 1.706). Gene set enrichment analysis linked high PS to immune-evasive pathways, including Notch and IL-6/JAK/STAT3 signaling, along with increased expression of DNA repair gene RAD50, suggesting a potential association with radiotherapy response.
Conclusion
This AI-based pathomics framework offers a robust and interpretable tool for immunoprofiling and outcome prediction, paving the way for precision radiotherapy and Treg-targeted therapeutic strategies in glioblastoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiotherapy, Cancer Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
- Key Laboratory of Radiation Biology of Fujian Higher Education Institutions, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
- Department of Pathology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
- Department of Radiology, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, China.
- School of Medical Imaging, Fujian Medical University, Fuzhou, China.
- School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
Zitieren
APA
Peng, S., Chen, J., Wang, X., Wang, X., Yue, Q., Lan, H., Zhang, J., Xie, Y., Yang, M., Xiao, J., Guo, C., Wang, Y., Wu, Z., Hong, J., & Zhang, M. (2026). AI-based pathomics model predicts regulatory T cell infiltration and radiotherapy response in IDH-wild-type glioblastoma. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1817892
Vancouver
Peng S, Chen J, Wang X, Wang X, Yue Q, Lan H, et al. AI-based pathomics model predicts regulatory T cell infiltration and radiotherapy response in IDH-wild-type glioblastoma. Frontiers in Immunology. 2026;17. doi:10.3389/fimmu.2026.1817892
BibTeX
@article{Peng2026,
author = {Peng, Shaoli and Chen, Jialei and Wang, Xuezhen and Wang, Xingfu and Yue, Qiuyuan and Lan, Hailin and Zhang, Jingru and Xie, Yuqi and Yang, Meiyan and Xiao, Jiayu and Guo, Chenyan and Wang, Yang and Wu, Zanyi and Hong, Jinsheng and Zhang, Mingwei},
title = {AI-based pathomics model predicts regulatory T cell infiltration and radiotherapy response in IDH-wild-type glioblastoma},
journal = {Frontiers in Immunology},
year = {2026},
volume = {17},
doi = {10.3389/fimmu.2026.1817892}
}
EUVIMED